A randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis.

Abstract

In this study, etoricoxib 90 mg once daily was more effective than either placebo or naproxen 500 mg twice daily for treating patients with RA over 12 weeks. Etoricoxib 90 mg was generally well tolerated in patients with RA.